198 related articles for article (PubMed ID: 21340468)
61. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
Calik MW; Carley DW
Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
[TBL] [Abstract][Full Text] [Related]
62. Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats.
Pattij T; Janssen MC; Schepers I; González-Cuevas G; de Vries TJ; Schoffelmeer AN
Psychopharmacology (Berl); 2007 Jul; 193(1):85-96. PubMed ID: 17387457
[TBL] [Abstract][Full Text] [Related]
63. Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle.
Wiley JL; Matthew Walentiny D; Vann RE; Baskfield CY
Behav Pharmacol; 2011 Sep; 22(5-6):480-8. PubMed ID: 21712709
[TBL] [Abstract][Full Text] [Related]
64. Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice.
Kamei J; Nagase H
Eur J Pharmacol; 2001 Apr; 418(1-2):141-5. PubMed ID: 11334876
[TBL] [Abstract][Full Text] [Related]
65. Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.
Scherma M; Fattore L; Satta V; Businco F; Pigliacampo B; Goldberg SR; Dessi C; Fratta W; Fadda P
Br J Pharmacol; 2013 Jun; 169(4):820-33. PubMed ID: 23072421
[TBL] [Abstract][Full Text] [Related]
66. Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice.
Darmani NA; Pandya DK
J Neural Transm (Vienna); 2000; 107(8-9):931-45. PubMed ID: 11041273
[TBL] [Abstract][Full Text] [Related]
67. The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors.
Steiner AA; Molchanova AY; Dogan MD; Patel S; Pétervári E; Balaskó M; Wanner SP; Eales J; Oliveira DL; Gavva NR; Almeida MC; Székely M; Romanovsky AA
J Physiol; 2011 May; 589(Pt 9):2415-31. PubMed ID: 21486787
[TBL] [Abstract][Full Text] [Related]
68. Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats.
Kelsey JE; Calabro S
Psychopharmacology (Berl); 2008 Jul; 198(4):461-6. PubMed ID: 17805516
[TBL] [Abstract][Full Text] [Related]
69. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
[TBL] [Abstract][Full Text] [Related]
70. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats.
Lichtman AH; Martin BR
Pharmacol Biochem Behav; 1997; 57(1-2):7-12. PubMed ID: 9164547
[TBL] [Abstract][Full Text] [Related]
71. Blockade of cannabinoid CB1 and CB2 receptors does not prevent the antipruritic effect of systemic paracetamol.
Saglam G; Gunduz O; Ulugol A
Acta Neurol Belg; 2014 Dec; 114(4):307-9. PubMed ID: 24399199
[TBL] [Abstract][Full Text] [Related]
72. The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific.
Niyuhire F; Varvel SA; Thorpe AJ; Stokes RJ; Wiley JL; Lichtman AH
Psychopharmacology (Berl); 2007 Apr; 191(2):223-31. PubMed ID: 17211653
[TBL] [Abstract][Full Text] [Related]
73. Medial prefrontal cannabinoid CB1 receptors modulate consolidation and extinction of cocaine-associated memory in mice.
Hu SS; Liu YW; Yu L
Psychopharmacology (Berl); 2015 May; 232(10):1803-15. PubMed ID: 25420608
[TBL] [Abstract][Full Text] [Related]
74. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
Fattore L; Spano S; Cossu G; Deiana S; Fadda P; Fratta W
Neuropharmacology; 2005 Jun; 48(8):1097-104. PubMed ID: 15910886
[TBL] [Abstract][Full Text] [Related]
75. Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant.
Martín-García E; Burokas A; Martín M; Berrendero F; Rubí B; Kiesselbach C; Heyne A; Gispert JD; Millán O; Maldonado R
J Neurochem; 2010 Mar; 112(5):1338-13351. PubMed ID: 20028452
[TBL] [Abstract][Full Text] [Related]
76. Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats.
Forget B; Hamon M; Thiébot MH
Psychopharmacology (Berl); 2005 Oct; 181(4):722-34. PubMed ID: 15986197
[TBL] [Abstract][Full Text] [Related]
77. Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats.
Sink KS; Segovia KN; Nunes EJ; Collins LE; Vemuri VK; Thakur G; Makriyannis A; Salamone JD
Psychopharmacology (Berl); 2009 Oct; 206(2):223-32. PubMed ID: 19588124
[TBL] [Abstract][Full Text] [Related]
78. Apparent CB
Grim TW; Morales AJ; Thomas BF; Wiley JL; Endres GW; Negus SS; Lichtman AH
J Pharmacol Exp Ther; 2017 Jul; 362(1):210-218. PubMed ID: 28442584
[TBL] [Abstract][Full Text] [Related]
79. The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats.
Kozan R; Ayyildiz M; Agar E
Epilepsia; 2009 Jul; 50(7):1760-7. PubMed ID: 19453709
[TBL] [Abstract][Full Text] [Related]
80. Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.
Baldassano S; Serio R; Mule' F
Eur J Pharmacol; 2008 Mar; 582(1-3):132-8. PubMed ID: 18234188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
